Correlation Between Akari Therapeutics and Terns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Akari Therapeutics and Terns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akari Therapeutics and Terns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akari Therapeutics PLC and Terns Pharmaceuticals, you can compare the effects of market volatilities on Akari Therapeutics and Terns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akari Therapeutics with a short position of Terns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akari Therapeutics and Terns Pharmaceuticals.
Diversification Opportunities for Akari Therapeutics and Terns Pharmaceuticals
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Akari and Terns is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Akari Therapeutics PLC and Terns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Terns Pharmaceuticals and Akari Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akari Therapeutics PLC are associated (or correlated) with Terns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Terns Pharmaceuticals has no effect on the direction of Akari Therapeutics i.e., Akari Therapeutics and Terns Pharmaceuticals go up and down completely randomly.
Pair Corralation between Akari Therapeutics and Terns Pharmaceuticals
Given the investment horizon of 90 days Akari Therapeutics PLC is expected to under-perform the Terns Pharmaceuticals. In addition to that, Akari Therapeutics is 2.3 times more volatile than Terns Pharmaceuticals. It trades about -0.21 of its total potential returns per unit of risk. Terns Pharmaceuticals is currently generating about -0.34 per unit of volatility. If you would invest 961.00 in Terns Pharmaceuticals on August 25, 2024 and sell it today you would lose (382.00) from holding Terns Pharmaceuticals or give up 39.75% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Akari Therapeutics PLC vs. Terns Pharmaceuticals
Performance |
| Timeline |
| Akari Therapeutics PLC |
| Terns Pharmaceuticals |
Akari Therapeutics and Terns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akari Therapeutics and Terns Pharmaceuticals
The main advantage of trading using opposite Akari Therapeutics and Terns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akari Therapeutics position performs unexpectedly, Terns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will offset losses from the drop in Terns Pharmaceuticals' long position.| Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
| Terns Pharmaceuticals vs. Capricor Therapeutics | Terns Pharmaceuticals vs. Akari Therapeutics PLC | Terns Pharmaceuticals vs. Soleno Therapeutics | Terns Pharmaceuticals vs. Bio Path Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance |